Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

LRRIQ3

From Wikipedia, the free encyclopedia
Protein-coding gene in the species Homo sapiens
LRRIQ3
Identifiers
AliasesLRRIQ3, LRRC44, leucine-rich repeats and IQ motif containing 3, leucine rich repeats and IQ motif containing 3
External IDsOMIM:617957;MGI:1921685;HomoloGene:23668;GeneCards:LRRIQ3;OMA:LRRIQ3 - orthologs
Gene location (Human)
Chromosome 1 (human)
Chr.Chromosome 1 (human)[1]
Chromosome 1 (human)
Genomic location for LRRIQ3
Genomic location for LRRIQ3
Band1p31.1Start74,026,015bp[1]
End74,198,187bp[1]
Gene location (Mouse)
Chromosome 3 (mouse)
Chr.Chromosome 3 (mouse)[2]
Chromosome 3 (mouse)
Genomic location for LRRIQ3
Genomic location for LRRIQ3
Band3|3 H4Start154,799,071bp[2]
End154,899,917bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • testicle

  • left testis

  • right testis

  • buccal mucosa cell

  • gonad

  • sperm

  • secondary oocyte

  • bronchial epithelial cell

  • right uterine tube

  • mucosa of paranasal sinus
Top expressed in
  • spermatid

  • spermatocyte

  • seminiferous tubule

  • zygote

  • gastrula

  • secondary oocyte

  • primary oocyte

  • lumbar spinal ganglion

  • lumbar subsegment of spinal cord

  • submandibular gland
More reference expression data
BioGPS
n/a
Orthologs
SpeciesHumanMouse
Entrez

127255

74435

Ensembl

ENSG00000162620

ENSMUSG00000028182

UniProt

A6PVS8
H0Y5F9

Q14DL3

RefSeq (mRNA)

NM_001105659
NM_145258
NM_001322315

NM_028938

RefSeq (protein)

NP_001099129
NP_001309244

NP_083214

Location (UCSC)Chr 1: 74.03 – 74.2 MbChr 3: 154.8 – 154.9 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

LRRIQ3 (Leucine-rich repeats and IQ motif containing 3), which is also known as LRRC44, is aprotein that in humans is encoded by the LRRIQ3gene.[5] It is predominantly expressed in the testes, and is linked to a number of diseases.[6]

Gene

[edit]

Locus

[edit]

LRRIQ3 is found on theminus strand of the end of theshort arm of humanchromosome 1 at 1p31.1.[7]

Overall Structure

[edit]

There are a total of 7exons in the putative sequence of LRRIQ3.[7]

mRNA

[edit]

Expression

[edit]

LRRIQ3 is expressed as 2 primaryisoforms, which produce proteins of length 624 amino acids and 464 amino acids respectively.[7] It is expressed at low levels in human and brown rat tissues,[8][9] with highest expression levels intestes tissue. There are relatively high expression levels inT cells, theepididymis, thekidney, and a number of glands.[10]

Protein

[edit]

General Characteristics and Compositional Features

[edit]

Human protein LRRIQ3 Isoform 1 consists of 624 amino acids, and has a molecular weight of 73.7 kDa. The isoelectric point of LRRIQ3 is 9.73, which suggests that LRRIQ3 isbasic at normal physiological pH (~7.4).[11] Additionally, there is strong evidence that human LRRIQ3 localizes to the plasma membrane from antibody staining.[12] LRRIQ3 is rich inlysine residues, with a total of 82 lysines. It is also slightly low onglycines.[13]

Domains and Motifs

[edit]

In total, there are 4conserved domains within LRRIQ3: 3leucine-rich repeats and 1IQ calmodulin-binding motif.[13] Leucine-rich repeats are typically involved in protein-protein interactions, and form a characteristic α/β horseshoefold.[14][15] An IQ motif provides a binding site for calmodulin (CaM) or CaM-like proteins.[16]

Secondary and Tertiary Structure

[edit]

LRRIQ3 is predicted to be mostlyalpha-helical instructure, including a long alpha-helicalC-terminal domain. It is also predicted to function as amonomer.[17][18][19][20]

The best model generated byI-TASSER[21] for LRRIQ3. The 3 leucine-rich repeats are shown in red, salmon, and magenta respectively. The IQ calmodulin-binding domain is shown in green.

Post-translational Modifications

[edit]

LRRIQ3 is predicted to undergo manypost-translational modifications. These includeO-GlcNAcylation,SUMOylation,ubiquitination, andphosphorylation.[22][23] LRRIQ3 is predicted to have 4 well conserved SUMOylation sites and 1 well conserved ubiquitination site.[22] A representation of these post-translational modifications is shown in the figure below.

A representation of the domains, motif, and post-translational modification sites of LRRIQ3, generated using DOG 2.0.[24]

Protein Interactions

[edit]

There is evidence that LRRIQ3 interacts with a number of proteins fromtwo-hybrid assays andaffinity chromatography. The proteins LRRIQ3 interact with includeLYN,NCK2,GNB4, andABL1.[25][26] These proteins are associated withcell signalling,cytoskeletal reorganization, andcell differentiation, as well as others.[27][28][29][30]

Homology and evolution

[edit]

Paralogs and Orthologs

[edit]

Noparalogs exists for LRRIQ3 in humans.[6] However, there are a number oforthologs, as reported byBLAST, some of which are listed below.[31] The number of years sincedivergence from the human protein, listed in "million of years ago (MYA)" below, were calculated usingTimeTree.[32]

Orthologs to Human LRRIQ3 Protein (NP_001099129.1)
Genus and SpeciesCommon NameDivergence from Human Lineage (MYA)Accession NumberSequence length (aa)Sequence Identity to Human ProteinSequence Similarity to Human Protein
Gorilla gorilla gorillaGorilla9.06XP_004026030.162497%98%
Macaca mulattaRhesus monkey29.44XP_001097148.262393%95%
Ursus maritimusPolar bear96XP_008689049.162576%87%
Felis catusDomestic cat96XP_003990274.162574%86%
Camelus ferusBactrian camel96XP_006178380.161873%84%
Oryctolagus cuniculusEuropean rabbit90XP_002715603.162271%83%
Bison bison bisonAmerican bison96XP_010847739.162570%82%
Trichechus manatus latirostrisManatee105XP_004369192.162370%82%
Loxodonta africanaAfrican elephant105XP_003411181.162568%80%
Condylura cristataStar-nosed mole96XP_004679575.162767%80%
Eptesicus fuscusBig brown bat96XP_008137759.162166%80%
Myotis davidiiVesper bat96XP_006775977.161865%79%
Rattus norvegicusNorway rat90NP_001019478.163362%77%
Mus MusculusHouse mouse90NP_083214.263363%76%
Sorex araneusCommon shrew96XP_004603704.161255%73%
Chrysemys picta belliiPainted turtle312XP_005285573.162440%56%
Pogona vitticepsBearded dragon312XP_020650341.165135%54%
Apteryx australis mantelliBrown kiwi312XP_013800580.166435%54%
Struthio camelus australisSouthern Ostrich312XP_009685099.162834%51%

Clinical significance

[edit]

LRRIQ3 is linked to a number of cancers. RNA-seq experiments have shown that LRRIQ3 is severely down-regulated (Log2-fold changes between -3.4 and -4.2) in a number of disease states, including pancreatic cancer, colorectal cancer, and breast cancer.[33][34][35]

References

[edit]
  1. ^abcGRCh38: Ensembl release 89: ENSG00000162620Ensembl, May 2017
  2. ^abcGRCm38: Ensembl release 89: ENSMUSG00000028182Ensembl, May 2017
  3. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^"LRRIQ3 Gene - GeneCards".
  6. ^ab"AceView entry on LRRIQ3".
  7. ^abc"LRRIQ3 leucine rich repeats and IQ motif containing 3 [Homo sapiens (human)] - Gene - NCBI".www.ncbi.nlm.nih.gov. Retrieved2018-04-30.
  8. ^"Lrriq3 protein abundance in PaxDb".pax-db.org. Retrieved2018-04-30.
  9. ^"LRRIQ3 protein abundance in PaxDb".pax-db.org. Retrieved2018-04-30.
  10. ^"GDS3834 / 3169".www.ncbi.nlm.nih.gov. Retrieved2018-05-06.
  11. ^"ExPASy - Compute pI/Mw tool".web.expasy.org. Retrieved2018-04-30.
  12. ^"Cell atlas - LRRIQ3 - The Human Protein Atlas".www.proteinatlas.org. Retrieved2018-04-30.
  13. ^abEMBL-EBI."SAPS < Sequence Statistics < EMBL-EBI".www.ebi.ac.uk. Retrieved2018-04-30.
  14. ^Kobe B, Deisenhofer J (October 1994). "The leucine-rich repeat: a versatile binding motif".Trends Biochem. Sci.19 (10):415–21.doi:10.1016/0968-0004(94)90090-6.ISSN 0968-0004.PMID 7817399.
  15. ^Enkhbayar P, Kamiya M, Osaki M, Matsumoto T, Matsushima N (February 2004). "Structural principles of leucine-rich repeat (LRR) proteins".Proteins.54 (3):394–403.doi:10.1002/prot.10605.ISSN 1097-0134.PMID 14747988.S2CID 19951452.
  16. ^Rhoads AR, Friedberg F (April 1997)."Sequence motifs for calmodulin recognition".FASEB J.11 (5):331–40.doi:10.1096/fasebj.11.5.9141499.ISSN 0892-6638.PMID 9141499.S2CID 1877645.
  17. ^Rost B (2001). "Review: protein secondary structure prediction continues to rise".J. Struct. Biol.134 (2–3):204–18.CiteSeerX 10.1.1.8.8169.doi:10.1006/jsbi.2001.4336.ISSN 1047-8477.PMID 11551180.
  18. ^Ouali M, King RD (June 2000)."Cascaded multiple classifiers for secondary structure prediction".Protein Sci.9 (6):1162–76.doi:10.1110/ps.9.6.1162.ISSN 0961-8368.PMC 2144653.PMID 10892809.
  19. ^Cuff JA, Barton GJ (August 2000). "Application of multiple sequence alignment profiles to improve protein secondary structure prediction".Proteins.40 (3):502–11.doi:10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q.ISSN 0887-3585.PMID 10861942.S2CID 855816.
  20. ^Jones DT (September 1999). "Protein secondary structure prediction based on position-specific scoring matrices".J. Mol. Biol.292 (2):195–202.doi:10.1006/jmbi.1999.3091.ISSN 0022-2836.PMID 10493868.S2CID 15506630.
  21. ^Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y (January 2015)."The I-TASSER Suite: protein structure and function prediction".Nat. Methods.12 (1):7–8.doi:10.1038/nmeth.3213.ISSN 1548-7091.PMC 4428668.PMID 25549265.
  22. ^abPagni M, Ioannidis V, Cerutti L, Zahn-Zabal M, Jongeneel CV, Falquet L (July 2004)."MyHits: a new interactive resource for protein annotation and domain identification".Nucleic Acids Res.32 (Web Server issue): W332–5.doi:10.1093/nar/gkh479.ISSN 0305-1048.PMC 441617.PMID 15215405.
  23. ^de Castro E, Sigrist CJ, Gattiker A, Bulliard V, Langendijk-Genevaux PS, Gasteiger E, Bairoch A, Hulo N (July 2006)."ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins".Nucleic Acids Res.34 (Web Server issue): W362–5.doi:10.1093/nar/gkl124.ISSN 1362-4962.PMC 1538847.PMID 16845026.
  24. ^Ren J, Wen L, Gao X, Jin C, Xue Y, Yao X (February 2009)."DOG 1.0: illustrator of protein domain structures".Cell Res.19 (2):271–3.doi:10.1038/cr.2009.6.ISSN 1001-0602.PMID 19153597.
  25. ^"Results - mentha: the interactome browser".mentha.uniroma2.it. Retrieved2018-04-30.
  26. ^"LRRIQ3 - Leucine-rich repeat and IQ domain-containing protein 3 - Homo sapiens (Human) - LRRIQ3 gene & protein".www.uniprot.org. Retrieved2018-04-30.
  27. ^Harder KW, Parsons LM, Armes J, Evans N, Kountouri N, Clark R, Quilici C, Grail D, Hodgson GS, Dunn AR, Hibbs ML (October 2001)."Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage".Immunity.15 (4):603–15.doi:10.1016/s1074-7613(01)00208-4.ISSN 1074-7613.PMID 11672542.
  28. ^Downes GB, Gautam N (December 1999). "The G protein subunit gene families".Genomics.62 (3):544–52.doi:10.1006/geno.1999.5992.ISSN 0888-7543.PMID 10644457.
  29. ^Tu Y, Li F, Wu C (December 1998)."Nck-2, a novel Src homology2/3-containing adaptor protein that interacts with the LIM-only protein PINCH and components of growth factor receptor kinase-signaling pathways".Mol. Biol. Cell.9 (12):3367–82.doi:10.1091/mbc.9.12.3367.ISSN 1059-1524.PMC 25640.PMID 9843575.
  30. ^Era T (July 2002). "Bcr-Abl is a "molecular switch" for the decision for growth and differentiation in hematopoietic stem cells".Int. J. Hematol.76 (1):35–43.doi:10.1007/BF02982716.PMID 12138893.S2CID 10269867.
  31. ^Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (October 1990). "Basic local alignment search tool".J. Mol. Biol.215 (3):403–10.doi:10.1016/S0022-2836(05)80360-2.ISSN 0022-2836.PMID 2231712.S2CID 14441902.
  32. ^"TimeTree :: The Timescale of Life".www.timetree.org. Retrieved2018-05-06.
  33. ^"Tissue expression of LRRIQ3 - Summary - The Human Protein Atlas".www.proteinatlas.org. Retrieved2018-05-06.
  34. ^github.com/gxa/atlas/graphs/contributors, EMBL-EBI Expression Atlas development team."Search results < Expression Atlas < EMBL-EBI".www.ebi.ac.uk. Retrieved2018-04-30.{{cite web}}:|last= has generic name (help)
  35. ^github.com/gxa/atlas/graphs/contributors, EMBL-EBI Expression Atlas development team."Experiment < Expression Atlas < EMBL-EBI".www.ebi.ac.uk. Retrieved2018-05-06.{{cite web}}:|last= has generic name (help)
Retrieved from "https://en.wikipedia.org/w/index.php?title=LRRIQ3&oldid=1215946517"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp